Myatro (Atropine Sulphate USP Eye Drops) 0.01% x 5ml

Myatro (Atropine Sulphate USP) 0.01% eye drops are sterile ophthalmic solutions used for pupil dilation and cycloplegia during eye exams. These 5ml drops provide a convenient single-use option for eye care professionals and patients. atropine sulphate eye drops 0.01% for mydriasis and cycloplegia in ophthalmology

Strength

0.01% x 5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Entod Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Myatro eye drops are commonly used to dilate the pupil (mydriasis) and temporarily paralyze the focusing ability of the eye (cycloplegia) during eye examinations. They help eye doctors get a clear view of the retina and other internal structures. These drops are also used to treat certain eye conditions that require pupil dilation for better visualization or management. what is atropine sulphate eye drops 0.01% used for

Side Effects

After application, Myatro eye drops typically cause the pupil to enlarge and the eye to lose its ability to focus on nearby objects. This effect usually begins within 30 minutes and can last for several hours or even days in some cases. Patients may experience temporary blurred vision or sensitivity to light after using these drops.

Precautions & Warnings

Keep the bottle tightly closed when not in use and store at room temperature away from direct light. Avoid touching the dropper tip to any surface to prevent contamination. Do not use if the solution changes color or becomes cloudy. Keep out of reach of children and pets. Discard any unused portion after opening.

Avoid Interactions

No significant drug interactions are reported with topical atropine eye drops. However, concurrent use of other eye medications may affect absorption or efficacy. Always inform your healthcare provider about all medications you are using before eye examinations. Alcohol and systemic anticholinergics may enhance certain effects.

Frequently Asked Questions

The effects typically begin within 30 minutes after application, with maximum dilation usually occurring within 1-2 hours.

These drops are specifically for pupil dilation and cycloplegia during eye exams, not for treating redness or irritation.

As these are administered by healthcare professionals during exams, missed doses are not applicable.

They are commonly used in pediatric eye exams but should only be administered under medical supervision.

Your vision will be temporarily affected; avoid driving or operating machinery until your vision returns to normal.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.